Another strategy to modulate autophagy and decrease the progerin levels in HGPS patients’ cells employed proteasome inhibitor MG132 as an activator of lysosomal degradation in response to proteasome inhibition. The gene discussed is LMNA; the disease is Hutchinson-Gilford progeria syndrome.